215 related articles for article (PubMed ID: 26678095)
1. CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value.
Pardanani A; Reichard KK; Zblewski D; Abdelrahman RA; Wassie EA; Morice Ii WG; Brooks C; Grogg KL; Hanson CA; Tefferi A; Chen D
Leukemia; 2016 Apr; 30(4):914-8. PubMed ID: 26678095
[TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
[TBL] [Abstract][Full Text] [Related]
3. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition.
Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100
[TBL] [Abstract][Full Text] [Related]
4. The Expressions of CD30 and CD123 of Mastocytosis in Taiwan.
Yang CF; Hsu CY
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):278-283. PubMed ID: 35384878
[TBL] [Abstract][Full Text] [Related]
5. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells.
Pardanani A; Lasho T; Chen D; Kimlinger TK; Finke C; Zblewski D; Patnaik MM; Reichard KK; Rowinsky E; Hanson CA; Brooks C; Tefferi A
Leukemia; 2015 Jul; 29(7):1605-8. PubMed ID: 25640886
[No Abstract] [Full Text] [Related]
7. Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.
Dasilva-Freire N; Mayado A; Teodosio C; Jara-Acevedo M; Álvarez-Twose I; Matito A; Sánchez-Muñoz L; Caldas C; Henriques A; Muñoz-González JI; García-Montero AC; Sánchez-Gallego JI; Escribano L; Orfao A
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696068
[TBL] [Abstract][Full Text] [Related]
8. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
[TBL] [Abstract][Full Text] [Related]
10. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
Tefferi A; Abdelmagid M; Al-Kali A; Patnaik M; Hogan WJ; Begna K; Gangat N; Orazi A; Chen D; Reichard KK; Pardanani A
Am J Hematol; 2024 Jan; 99(1):21-27. PubMed ID: 37772442
[TBL] [Abstract][Full Text] [Related]
11. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
12. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.
Shah S; Pardanani A; Elala YC; Lasho TL; Patnaik MM; Reichard KK; Hanson CA; Ketterling RP; Tefferi A
Am J Hematol; 2018 Dec; 93(12):1461-1466. PubMed ID: 30152525
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.
Valent P; Sotlar K; Horny HP
Leuk Lymphoma; 2011 May; 52(5):740-4. PubMed ID: 21261503
[TBL] [Abstract][Full Text] [Related]
15. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
16. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
Sotlar K; Horny HP; Simonitsch I; Krokowski M; Aichberger KJ; Mayerhofer M; Printz D; Fritsch G; Valent P
Am J Surg Pathol; 2004 Oct; 28(10):1319-25. PubMed ID: 15371947
[TBL] [Abstract][Full Text] [Related]
17. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with
Hwang SM; Kim BJ; Lee JS; Seong MW; Seo SH; Paik JH; Kim SA; Lee JY; Lee JO; Chang YH; Bang SM
Ann Lab Med; 2022 Nov; 42(6):678-682. PubMed ID: 35765876
[TBL] [Abstract][Full Text] [Related]
20. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
